Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study
Scott Antonia(Moffitt Cancer Center), Sarah B. Goldberg(Yale Cancer Center), Ani Sarkis Balmanoukian(Angeles Clinic and Research Institute), Jamie E. Chaft(Memorial Sloan Kettering Cancer Center), Rachel E. Sanborn(Providence Portland Medical Center), Ashok Gupta, Rajesh Narwal, Keith E. Steele, Yu Gu, Joyson Karakunnel, Naiyer A. Rizvi(Columbia University Irving Medical Center)
Cited by 594Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis